Ryoo BY - Search Results

1

Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX.

Lee SH, Hwang DW, Yoo C, Kim KP, Kang S, Jeong JH, Oh D, Song TJ, Lee SS, Park DH, Seo DW, Park JH, Song KB, Lee JH, Lee W, Park Y, Kwak BJ, Chang HM, Ryoo BY, Kim SC. Lee SH, et al. Among authors: ryoo by. Cancer Res Treat. 2023 Jul;55(3):956-968. doi: 10.4143/crt.2022.409. Epub 2023 Feb 27. Cancer Res Treat. 2023. PMID: 36915253 Free PMC article.

2

Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.

Ryoo BY, Kang YK, Im YH, Kim YJ, Kim BS, Kim TY, Jung SH, Park JH, Baek HJ, Kim YC, Shim YM, Kim CM, Zo JI. Ryoo BY, et al. Am J Clin Oncol. 1999 Jun;22(3):253-7. doi: 10.1097/00000421-199906000-00008. Am J Clin Oncol. 1999. PMID: 10362331 Clinical Trial.

3

Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients.

Park YH, Lee JJ, Ryu MH, Kim SY, Kim DH, Do YR, Lee KH, Oh SJ, Kim YK, Suh CW, Heo DS, Ryoo BY, Kim JK, Song HS, Lee WS, Kim HJ, Bang YJ, Yang SH, Sohn SK, Kang YK; Lymphoma Study Division of the Korean Cancer Study Group. Park YH, et al. Among authors: ryoo by. Ann Hematol. 2006 Apr;85(4):257-62. doi: 10.1007/s00277-005-0060-6. Epub 2006 Jan 17. Ann Hematol. 2006. PMID: 16416337

4

The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.

Kwon JM, Park YH, Kang JH, Kim K, Ko YH, Ryoo BY, Lee SS, Lee SI, Koo HH, Kim WS. Kwon JM, et al. Among authors: ryoo by. Ann Hematol. 2006 Jul;85(7):463-8. doi: 10.1007/s00277-006-0081-9. Epub 2006 Mar 14. Ann Hematol. 2006. PMID: 16534596

5

High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases.

Kim HJ, Bang SM, Lee J, Kwon HC, Suh C, Kim HJ, Lee JH, Ryoo BY, Park YH, Kwon JM, Oh SY, Lee HR, Kim K, Jung CW, Park K, Kim WS. Kim HJ, et al. Among authors: ryoo by. Bone Marrow Transplant. 2006 May;37(9):819-24. doi: 10.1038/sj.bmt.1705349. Bone Marrow Transplant. 2006. PMID: 16547486

6

Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumours.

Ryu MH, Kang YK, Jang SJ, Kim TW, Lee H, Kim JS, Park YH, Lee SS, Ryoo BY, Chang HM, Lee JL, Yook JH, Kim BS, Lee JS. Ryu MH, et al. Among authors: ryoo by. Histopathology. 2007 Sep;51(3):379-89. doi: 10.1111/j.1365-2559.2007.02797.x. Histopathology. 2007. PMID: 17727479

7

Cross-sectional study of imatinib plasma trough levels in patients with advanced gastrointestinal stromal tumors: impact of gastrointestinal resection on exposure to imatinib.

Yoo C, Ryu MH, Kang BW, Yoon SK, Ryoo BY, Chang HM, Lee JL, Beck MY, Kim TW, Kang YK. Yoo C, et al. Among authors: ryoo by. J Clin Oncol. 2010 Mar 20;28(9):1554-9. doi: 10.1200/JCO.2009.26.5785. Epub 2010 Feb 22. J Clin Oncol. 2010. PMID: 20177019

8

Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailability.

Kim KP, Ryu MH, Yoo C, Ryoo BY, Choi DR, Chang HM, Lee JL, Beck MY, Kim TW, Kang YK. Kim KP, et al. Among authors: ryoo by. Cancer Chemother Pharmacol. 2011 Aug;68(2):285-91. doi: 10.1007/s00280-010-1479-6. Epub 2010 Oct 19. Cancer Chemother Pharmacol. 2011. PMID: 20957481

9

Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patients.

Yoon DH, Ryu MH, Ryoo BY, Beck M, Choi DR, Cho Y, Lee JL, Chang HM, Kim TW, Kang YK. Yoon DH, et al. Among authors: ryoo by. Invest New Drugs. 2012 Apr;30(2):819-27. doi: 10.1007/s10637-010-9593-1. Epub 2010 Nov 23. Invest New Drugs. 2012. PMID: 21104107

10

Changes in imatinib plasma trough level during long-term treatment of patients with advanced gastrointestinal stromal tumors: correlation between changes in covariates and imatinib exposure.

Yoo C, Ryu MH, Ryoo BY, Beck MY, Chang HM, Lee JL, Kim TW, Kang YK. Yoo C, et al. Among authors: ryoo by. Invest New Drugs. 2012 Aug;30(4):1703-8. doi: 10.1007/s10637-011-9633-5. Epub 2011 Jan 14. Invest New Drugs. 2012. PMID: 21234641 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters